Therapies requiring high volume injections are becoming more common across a broad range of therapeutic areas. For the growing category of injectables, multiple advances in pharmaceutical and device technologies play a role in achieving desired patient outcomes in adherence, safety and quality of life.
Through market and patient research, the key enablers for these outcomes include transitioning from intravenous to subcutaneous injections, combination therapies, as well as new device technologies. Together these enablers are leading to new possibilities and improving patient outcomes.
This webinar will explore why adherence, safety and quality of life are important for patients, and how these key enablers contribute towards positive outcomes. We will also discuss existing challenges, such as drug development, regulatory, patient accessibility, and how device technologies can further improve patient outcomes.